Gene · 134
Papers2,244
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,244
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Network Pharmacology Analysis of the Potential Pharmacological Mechanism of a Sleep Cocktail. | Biomolecules | 2024 | 38927034 | PubTator, text mining | PubMed |
| Evaluation of glomerular hemodynamic changes by sodium-glucose-transporter 2 inhibition in type 2 diabetic rats using in vivo imaging. | Kidney Int | 2024 | 38801992 | PubTator, text mining | PubMed |
| Molecular Mechanisms and Therapeutic Potential of Gabapentin with a Focus on Topical Formulations to Treat Ocular Surface Diseases. | Pharmaceuticals (Basel) | 2024 | 38794193 | PubTator, text mining | PubMed |
| Agrin-Lrp4 pathway in hippocampal astrocytes restrains development of temporal lobe epilepsy through adenosine signaling. | Cell Biosci | 2024 | 38783336 | PubTator, text mining | PubMed |
| Development of Putative Bivalent Dicovalent Ligands for the Adenosine A1 Receptor. | Chembiochem | 2024 | 38777792 | PubTator, text mining | PubMed |
| Activation of hepatic adenosine A1 receptor ameliorates MASH via inhibiting SREBPs maturation. | Cell Rep Med | 2024 | 38718795 | PubTator, text mining | PubMed |
| Analgesic candidate adenosine A 3 receptors are expressed by perineuronal peripheral macrophages in human dorsal root ganglion and spinal cord microglia. | Pain | 2024 | 38691673 | PubTator, text mining | PubMed |
| Non-invasive caffeinated-nanovesicles as adipocytes-targeted therapy for cellulite and localized fats. | Int J Pharm X | 2024 | 38524143 | PubTator, text mining | PubMed |
| Activation of hepatic adenosine A1 receptor ameliorates MASH via inhibiting SREBPs maturation. | Cell Rep Med | 2024 | 38508143 | PubTator, text mining | PubMed |
| Beyond the Nucleus: Plastic Chemicals Activate G Protein-Coupled Receptors. | Environ Sci Technol | 2024 | 38440973 | PubTator, text mining | PubMed |
| Elucidating the role of intrinsic adenosine A1 receptors in acute alcoholism using human-induced pluripotent stem cell-derived hepatocytes. | Biosci Rep | 2024 | 38419509 | PubTator, text mining | PubMed |
| AKT2S128/CCTαS315/319/323-positive cancer-associated fibroblasts (CAFs) mediate focal adhesion kinase (FAK) inhibitors resistance via secreting phosphatidylcholines (PCs). | Signal Transduct Target Ther | 2024 | 38280862 | PubTator, text mining | PubMed |
| Trends in Acupuncture Therapy for Microcirculation and Hemorheology from 1998 to 2023: A Bibliometric and Visualized Study. | J Pain Res | 2024 | 38223661 | PubTator, text mining | PubMed |
| Neuroprotective effects of cordycepin inhibit glutamate-induced apoptosis in hippocampal neurons. | Cell Stress Chaperones | 2024 | 38219840 | PubTator, text mining | PubMed |
| Immunological studies on acupuncture and moxibustion treatment of rheumatoid arthritis: A review. | Medicine (Baltimore) | 2024 | 38215134 | PubTator, text mining | PubMed |
| Progress in the clinical effects and adverse reactions of ticagrelor. | Thromb J | 2024 | 38200557 | PubTator, text mining | PubMed |
| The potential value of the Purinergic pathway in the prognostic assessment and clinical application of kidney renal clear cell carcinoma. | Aging (Albany NY) | 2024 | 38180750 | PubTator, text mining | PubMed |
| Inhibitory effect of truncated isoforms on GPCR dimerization predicted by combinatorial computational strategy. | Comput Struct Biotechnol J | 2024 | 38173876 | PubTator, text mining | PubMed |
| Research progress in the management of vascular disease with cannabidiol: a review. | J Cardiothorac Surg | 2024 | 38172934 | PubTator, text mining | PubMed |
| Exploring an immortal Turritopsis sp. as a less conventional natural system for study of aging. | Biochem Biophys Rep | 2024 | 38155942 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/134/papers?page=6